Leucocyte arylsulphatase A activity in schizophrenia and depression

Author： Pelescaron A.M.   Jakovljevicacute M.   Kraccaron un I.   Ccaron accaron icacute A.   Miliccaron evicacute Z..  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 321-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Depression in Patients with Schizophrenia: Prevalence, and Diagnostic and Treatment Considerations

By Hausmann A.  

CNS Drugs, Vol. 14, Iss. 4, 2000-10 ,pp. : 289-299

Adis International

Access to resources Recommend Favorite

COX-2 Inhibition in Schizophrenia and Major Depression

By  

Current Pharmaceutical Design, Vol. 14, Iss. 14, 2008-05 ,pp. : 1452-1465

Bentham Science Publishers

Access to resources Recommend Favorite

Ocaperidone exhibits antipsychotic activity in schizophrenia

By  

Inpharma, Vol. 1, Iss. 1484, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Rimonabant: Anxiety and depression, followed by schizophrenia relapse: case report

By  

Reactions Weekly, Vol. 1, Iss. 1297, 2010-01 ,pp. : 44-44

Adis International

Access to resources Recommend Favorite

Smoking impact on CYP1A2 activity in a group of patients with schizophrenia

By Bozikas V.P.   Papakosta M.   Niopas I.   Karavatos A.   Mirtsou-Fidani V.  

European Neuropsychopharmacology, Vol. 14, Iss. 1, 2004-01 ,pp. : 39-44

Elsevier

Access to resources Recommend Favorite